Product Information

TADALAFIL 5 MG TABLET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.1078 per EA under NDC 33342026607. Its NADAC has been published 331 times since Jul 15, 2020.

FDA first approved this application on Oct 7, 2019. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TADALAFIL 5 MG TABLET

Tadalafil
$0.1078per EA

Strength

5 mg/1

NDC

33342026607

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

TADALAFIL

Approval Type

Generic (ANDA)

FDA Application

ANDA207244

FDA Approved

10/7/2019

TE Code

AB1

On Market Since

10/8/2019

Pharmacological Classes

Phosphodiesterase 5 Inhibitor
Phosphodiesterase 5 Inhibitors

Price Statistics

The NADAC for TADALAFIL 5 MG TABLET has been published 331 times since Jul 15, 2020, and over the history we have for it it has declined 60.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1078 per EA
All-time high$0.2716 (Dec 16, 2020)
All-time low$0.0842 (Nov 20, 2024)
52-week high$0.1162
52-week low$0.1014
Median price$0.1418
Average price$0.1491
Largest weekly change+47.6% (Aug 21, 2024)
Weeks tracked331
Tracking sinceJul 15, 2020

Price History

1W

0.0%

1M

+4.4%

3M

+6.2%

6M

+2.4%

1Y

-12.2%

3Y

-28.9%

5Y

-20.9%

All

-60.0%

Generic Alternatives

The matcher finds 14 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TADALAFIL 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TADALAFIL 5 MG TABLET, manufactured by Macleods Pharmaceuticals Limited, is $0.1078 per EA (NDC 33342026607), effective Nov 11, 2026.

How has the price of TADALAFIL 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for TADALAFIL 5 MG TABLET has declined 60.0%. It has been tracked across 331 weekly CMS publications since Jul 15, 2020.

What are the highest and lowest recorded NADAC prices for TADALAFIL 5 MG TABLET?

Since Jul 15, 2020, the NADAC for TADALAFIL 5 MG TABLET has ranged from a low of $0.0842 (Nov 20, 2024) to a high of $0.2716 (Dec 16, 2020), with a median of $0.1418 per EA.

Are there cheaper alternatives to TADALAFIL 5 MG TABLET?

Yes. 14 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TADALAFIL 5 MG TABLET, is $0.1043 per EA — about 3% below TADALAFIL 5 MG TABLET.

Who manufactures TADALAFIL 5 MG TABLET?

TADALAFIL 5 MG TABLET (NDC 33342026607) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.